feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

trending

Cognizant profit rises 18.7%

trending

Qualcomm stock falls on shortages

trending

JSW Cement Q3 profit rises

trending

HAL shares tumble after AMCA

trending

Bharat Taxi launches in Delhi

trending

CTET admit card releasing soon

trending

Suzlon Energy Q3 results up

trending

Trent share price cautious outlook

trending

Pakistan India T20 boycott

Home / Health / New Glasses Slow Kids' Nearsightedness

New Glasses Slow Kids' Nearsightedness

1 Dec, 2025

•

Summary

  • New FDA-approved lenses slow myopia progression in children.
  • Specialized lenses use ringed dots to refocus light on the retina.
  • The new glasses are expected to cost $450 and are insurance-covered.

The FDA has approved a novel lens technology designed to slow the progression of myopia, or nearsightedness, in children aged 6 to 12. This innovative approach, previously available internationally, is now rolling out in the United States. The Essilor Stellest lenses feature 11 concentric rings with tiny dots, engineered to redirect light onto the retina in a way that may inhibit eye elongation.

Studies submitted to the FDA indicated significant results, with children experiencing a 70% reduction in myopia progression and a 50% decrease in eye lengthening over a two-year period. Experts believe this technology could prevent long-term complications associated with severe myopia, such as retinal detachment and glaucoma, potentially safeguarding vision into adulthood.

While the suggested retail price is $450, major U.S. vision insurance providers are expected to cover the cost for eligible children. This new option offers an alternative to existing treatments like MiSight contact lenses or off-label medicated eye drops, addressing potential parental hesitancy regarding contact lenses for younger children.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Myopia, or nearsightedness, makes distant objects blurry. Its increase is linked to more indoor screen time and close-up activities.
These lenses use 11 concentric rings with tiny dots to refocus light on the retina, aiming to slow eye elongation.
The glasses offer an alternative for parents hesitant about putting younger children in contact lenses.

Read more news on

Healthside-arrow

You may also like

Zyn Pouches: FDA Weighs 'Reduced Risk' Claims

22 Jan • 109 reads

article image

Listeria Alert: Pecorino Cheese Recalled Nationwide

16 Jan • 82 reads

article image

FDA Approves Oral Wegovy: Game Changer for Dieters?

23 Dec, 2025 • 295 reads

article image

ByHeart Formula: Years of Contamination Feared

11 Dec, 2025 • 339 reads

article image

FDA Probes COVID Vaccine Deaths in Adults & Kids

11 Dec, 2025 • 298 reads